HIGHLIGHTS
- who: Jinlu Zhao and collaborators from the Department of General Surgery, u03a4he Fourth Affiliated Hospital of Harbin Medical University, Harbin, China have published the research: Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer, in the Journal: Journal of Oncology 4X of 31/08/2022
- what: The authors aimed to investigate the expression, prognostic value, and potential molecular role of CDCP1 in BrCa using multiple public datasets and an inhouse cohort. The authors reported that CDCP1 was significantly overexpressed in BrCa tissues and highly expressed in the HER2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.